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C14th International Congress on Infectious Diseases (ICID) Abs
to tetracycline, co-trimoxazole and erythromycin were vari-
able during the study period.
Conclusion: The number of isolates reported through the
Network was different from those published by the annual
summaries of cholera cases in WHO Weekly Epidemiologi-
cal Record. These discrepancies reﬂect the limitations in
surveillance and reporting systems. Data demonstrate that
choleare is present in the Americas Region with potential
for oubreaks. Laboratory surveillance should be integrated
in the national surveillance systems for accurate information
on outbreaks and burden of disease.
doi:10.1016/j.ijid.2010.02.2121
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Background: Inﬂuenza viruses cause a highly contagious
acute respiratory disease that has resulted in epidemic and
pandemic in human populations over the years. In February
2006, poultry outbreaks of highly pathogenic avian inﬂuenza
A (H5N1) virus were conﬁrmed in Nigeria. A survey was
therefore set up to assess the role of inﬂuenza A virus in
several respiratory tract infections seen in some hospitals in
some hospitals in Lagos, Nigeria.
Methods: From April, 2008 to November 2009, sterile
swabs were used to swab the throat of 182 patients present-
ing with ﬂu-like symptoms. These patients had no knowledge
of exposure to any strain of inﬂuenza virus. Viral RNA were
eluted in transport media, extracted, transcribed and sub-
sequently, the polymerase chain reaction (PCR) was used to
amplify the complementary DNA.
Results: Seventy-eight (42.9%) tested positive for
inﬂuenza A virus: 53.8% and 46.2% were males and females
respectively. Overall, sampling was done in exactly the same
way for the wet (rainy) and dry seasons but 41 (52.6%) of the
positive patients were seen during the wet season while 37
(47.4%) were seen in the dry season. There was no statisti-
cally signiﬁcant difference between these values (p < 0.05).
Conclusion: The results shows inﬂuenza A virus plays
a signiﬁcant role in respiratory tract infections seen all
through the year. As diagnosis is hardly considered in the
management of these infections, it is advised that there
should be continued surveillance for inﬂuenza A infections
in humans. Seroprevalence investigations are also needed to
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elevance of infectious diseases in nephrology patients: A
etrospective single center Review of twenty renal biop-
ies
. Nguyen
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Background: Previous studies have examined the speciﬁc
ntities of renal pathology with bacterial/viral diseases.
ew have broadly studied infectious disease relevance
n patients affected by current immunosuppressive and
ytotoxic regimens. This retrospective was performed on
atients who had renal biopsy to assess renal dysfunctions.
Methods: Twenty transplant/non-transplant renal biop-
ies performed between January 1, 2009 and November 30,
009 were randomly reviewed. Concurrent infectious dis-
ases were identiﬁed.
Results: The biopsies belonged to 13 males & 6 females
7 cases: native biopsies & 13 cases: transplant biopsies). Of
he transplant cases, 4 cases showed concurrent infectious
iseases (23%). These cases included 2 cases (15%) from 1
atient with recurrent polyoma nephropathy, 2 cases (15%)
ith chronic allograft nephropathy (including 1 case with
yelonephritis/reﬂux nephropathy & 1 case with HIV having
cute tubular injury). The others, with no infectious compli-
ations, included 5 cases (38%) with delayed graft functions,
case (8%) with severe transplant glomerulopathy, and 1
ase (8%) with chronic allograft nephropathy/recurrence of
ocal proliferative lupus nephropathy. Of the native renal
ases, 2 cases (29%) were identiﬁed with infectious com-
lication. The cases include 1 case (14%) with HIV/HCV
& hypertension/chronic kidney disease/recurrent bacte-
ial pneumonia) and 1 case with urethral stenosis and
hronic pyelonephritis. The remaining cases without infec-
ions include recurrent focal segmental glomerulosclerosis
FSGS), 1 case (14%) with membranous lupus nephropathy,
case (14%) with focal proliferative nephritis & Henoch-
chonlein Purpura (HSP), 1 case with minimal change (14%)
n complete remission, and 1 hypertensive nephropathy
ase with thrombotic microangiopathy (TMA). With current
mmunosuppressive/cytotoxic drug regimen and careful fol-
ow up, few patients demonstrate concurrent infectious
isease. The few affected patients have history of urinary
ract infections associated urinary tract reﬂux/obstruction.
ecurrent polyoma viral nephropathy, seen in 2 cases of
pediatric patient, needed decreased immunosuppressive
egimen, altered cytotoxic therapy, and antiviral medica-
ion. One native kidney case of a patient with HIV/Hepatitis
infection showed recurrent pneumonia.
Conclusion: In this small review, most native & all
ecently transplanted specimens (within several months)
id not show systemic infections despite heavy initial dose
f cytotoxic/immunosuppressive regimen. Few affected
ases showed underlying chronic conditions such as HIV or
bstructive/reﬂux uropathy. Current regimens and clinical
anagement of medical renal diseases/renal transplants
